Royalty Pharma Reports Second Quarter 2022 Results

Go back to Royalty Pharma Reports Second Quarter 2022 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 62.32 +0.91 (1.48%)
Previous Close $61.41    52 Week High $3.48 
Open $61.81    52 Week Low $0.80 
Day High $62.58    P/E N/A 
Day Low $61.61    EPS $-1.54 
Volume 2,629,291